Skip to main content

and
  1. Article

    Open Access

    Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF

    Cyclophosphamide, methotrexate and fluorouracil adjuvant combination chemotherapy for breast cancer is currently used for the duration of six monthly courses. We performed a joint analysis of two studies on th...

    M Colleoni, H J Litman, M Castiglione-Gertsch, W Sauerbrei in British Journal of Cancer (2002)